Evidence map›Paper›PMID 33683509›Full record

ReviewHeart failure reviews2022

How to deal with low-flow low-gradient aortic stenosis and reduced left ventricle ejection fraction: from literature review to tips for clinical practice.

F Contorni, M Fineschi, A Iadanza, A Santoro, G E Mandoli, M Cameli

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart failure reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

F ContorniDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy. francescocontorni01@gmail.com.ORCID 0000-0003-1257-5197
M FineschiDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
A IadanzaDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
A SantoroDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
G E MandoliDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
M CameliDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-flow low-gradient aortic stenosis (LFLG AS) with reduced left ventricle ejection fraction (LVEF) is still a diagnostic and therapeutic challenge. The aim of this paper is to review the latest evidences about the assessment of the valvular disease, usually difficult because of the low-flow status, and the therapeutic options. Special emphasis is given to the available diagnostic tools for the characterization of LFLG AS without functional reserve at stress echocardiography and to the factors that clinicians should evaluate to choose between surgical aortic valve repair, transcatheter aortic valve implantation, or medical therapy.

Indexed as

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementHeart VentriclesHumansStroke VolumeTreatment OutcomeAfter TAVI paravalvular leakAfter TAVI permanent pacemaker implantationLow-flow low-gradient aortic stenosisSAVR vs TAVITAVI in bicuspid aortic valveTAVI in low-flow low-gradient aortic stenosis

Identifiers

PMID33683509
PMCPMC8898219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.